Songcheng Performance(300144)
Search documents
宋城演艺(300144) - 关于控股股东部分股份解除质押并再质押的公告
2025-12-15 10:12
证券代码:300144 证券简称:宋城演艺 公告编号:2025-073 宋城演艺发展股份有限公司 关于控股股东部分股份解除质押并再质押的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 宋城演艺发展股份有限公司(以下简称"公司")近日接到公司控股股东杭 州宋城集团控股有限公司(以下简称"宋城集团")通知,获悉宋城集团将其所 持有公司的部分股份办理了解除质押业务,并对该部分股份再次进行了质押,具 体事项如下: 二、股东股份被质押基本情况 | 股东 | 是否为第一 | 本次质押 | 占其所 | 占公司 | 是否 | 是否为 | 质押起始 | 质押到期 | | 质押 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 名称 | 大股东及其 | 数量(股) | 持股份 | 总股本 | 为限 | 补充质 | 日 | 日 | 质权人 | 用途 | | | 一致行动人 | | 比例 | 比例 | 售股 | 押 | | | | | | 宋城 集团 | | | | | | | 202 ...
社会服务行业专题报告十一:酒店价格回正,REITs助力文旅资产盘活提速
Shenwan Hongyuan Securities· 2025-12-14 14:36
Investment Rating - The report rates the industry as "Overweight," indicating a positive outlook for the sector compared to the overall market performance [2]. Core Insights - The report highlights a moderate recovery in consumer spending, with tourism-related prices showing strong performance. The national CPI increased by 0.7% year-on-year in November 2025, reflecting a continued recovery in consumer spending [2][7]. - Hotel prices have shown resilience despite seasonal demand fluctuations, with the average hotel room price maintaining positive growth year-on-year. The RevPAR (Revenue Per Available Room) has only slightly declined, indicating a shift from a volume-driven recovery to a price-stabilized and optimized operational approach [2][8]. - The introduction of REITs (Real Estate Investment Trusts) in the service industry is expected to clarify the asset securitization path for various service sectors, including tourism and hospitality. This initiative aims to revitalize existing assets and improve financial structures [2][22][23]. Summary by Sections 1. Hotel Structure Differentiation and Price Resilience - The hotel industry is experiencing a seasonal decline in occupancy rates, but average room prices remain stable, with an ADR (Average Daily Rate) of 388.8 CNY per night in early December, up 4.3% year-on-year [8][10]. - The RevPAR for the week ending December 6, 2025, was 233 CNY per night, showing only a 0.4% decline year-on-year, indicating a recovery phase focused on price stability and operational efficiency [8][10]. 2. REITs Supporting Asset Securitization in the Service Industry - The newly released REITs project industry scope includes cultural tourism infrastructure and commercial facilities, allowing for a clearer path to asset securitization for hotels and tourist attractions [22][23]. - The report emphasizes that the inclusion of high-quality service industry assets in the REITs framework will enhance cash flow stability and operational efficiency, ultimately benefiting the valuation and investment landscape of the sector [22][24]. 3. Valuation of Key Industry Companies - The report provides a detailed valuation of key companies in the tourism and hospitality sectors, including metrics such as market capitalization and PE ratios, indicating a diverse range of investment opportunities [26]. - Notable companies highlighted for investment consideration include tourism sites like Sanxia Tourism and hotels like Shoulu Hotel and Huazhu [26].
宋城演艺(300144) - 2025年第三次临时股东会决议公告
2025-12-11 11:04
2025 年第三次临时股东会决议公告 证券代码:300144 证券简称:宋城演艺 公告编号:2025-072 本公司及董事会全体成员保证公告内容真实、准确和完整,没有虚假记 载、误导性陈述或重大遗漏。 重要内容提示: 宋城演艺发展股份有限公司 1、本次股东会未出现否决议案的情形。 2、本次股东会不涉及变更以往股东会已通过的决议。 一、会议召开和出席情况 (一)会议召开情况 1、会议召集人:公司董事会 2、会议召开时间: (1)现场会议召开时间:2025 年 12 月 11 日(星期四)15:00 (2)网络投票时间:通过深圳证券交易所交易系统进行网络投票的具体时 间为:2025 年 12 月 11 日上午 9:15-9:25,9:30-11:30,下午 13:00-15:00;通过深 圳证券交易所互联网投票系统投票的具体时间为:2025 年 12 月 11 日上午 9:15 至下午 15:00 期间的任意时间。 3、会议召开方式:本次股东会采取现场投票与网络投票相结合的方式。 4、会议召开地点:浙江省杭州市之江路 148 号公司会议室。 5、会议主持人:公司董事长张娴女士。 6、本次会议的召开符合有关法律、行 ...
宋城演艺(300144) - 浙江六和律师事务所关于宋城演艺发展股份有限公司2025年第三次临时股东会的法律意见书
2025-12-11 11:04
中国 ● 杭州 ● 求是路 8 号公元大厦北楼 20F 电话:0571—87206788 传真:0571—87206789 电子信箱:liuhe@mail.hz.zj.cn 网 址:www.liuhelaw.com 浙江六和律师事务所 关 于 宋城演艺发展股份有限公司 2025 年第三次临时股东会的法律意见书 1 浙江六和律师事务所 关于宋城演艺发展股份有限公司 2025 年第三次临时股东会的法律意见书 浙六和法意(2025)第 2470 号 致:宋城演艺发展股份有限公司 根据《中华人民共和国证券法》(以下简称"《证券法》")《中华人民共和 国公司法》(以下简称"《公司法》")和中国证券监督管理委员会《上市公司 股东会规则》(以下简称"《股东会规则》")等法律、法规和规范性文件的要求及 《宋城演艺发展股份有限公司章程》(以下简称"公司章程")的规定,浙江六 和律师事务所(以下简称"本所")接受宋城演艺发展股份有限公司(以下简称 "公司"或者"宋城演艺")的委托,指派陈独伊律师、张天涵律师参加公司 2025 年第三次临时股东会(以下简称"本次股东会"),对本次股东会的召集和召开程 序、出席会议人员资格、表决程序 ...
12月10日重要公告一览
Xi Niu Cai Jing· 2025-12-10 02:38
Group 1 - Jinggong Technology signed a sales contract with Hubei Yuchuang worth 729 million yuan, accounting for 42.16% of the company's audited revenue for 2024 [1] - Heshun Electric is expected to win a bid for a State Grid procurement project worth 107 million yuan, representing 24.97% of the company's 2024 revenue [2] - Yongmaotai plans to invest approximately 400 million yuan in a new intelligent manufacturing project for magnesium-aluminum alloy materials [3] Group 2 - Longi Green Energy announced the termination of its plan to issue global depositary receipts abroad, stating it will not significantly impact its operations [4] - Bai Ao Intelligent is expected to win bids for projects totaling 27.5 million yuan [5] - Lian Biological is planning a change of control and asset purchase, leading to a temporary suspension of its stock [6] Group 3 - Bo Rui Communication intends to acquire 51% of Meijing Technology for 66.49 million yuan [7] - Huitai Medical plans to repurchase shares worth 200 to 250 million yuan for employee stock ownership plans [8] - Yifang Biological is planning to issue H-shares and apply for listing on the Hong Kong Stock Exchange [9] Group 4 - Jiuqiang Biological's shareholders signed an agreement for the transfer of 5% of the company's shares to China National Pharmaceutical Investment [11] - Songcheng Performing Arts plans to repurchase shares worth 100 to 200 million yuan for capital reduction [12] - Zhonghong Medical's subsidiary is expected to be selected for a centralized procurement project in Jiangxi Province [13] Group 5 - Xingfu Electronics plans to invest 480 million yuan in a new electronic-grade phosphoric acid project [14] - Jiaao Environmental Protection's stock will be subject to risk warnings due to an administrative penalty [15] - ST Nuotai received a drug registration certificate for a new injection [16] Group 6 - Haimo Technology plans to sell its controlling subsidiary, Xian Sitian Instrument, for 370 million yuan [17] - Jingce Electronics signed multiple sales contracts with a single customer totaling 433 million yuan [18] - Donghua Testing's controlling shareholder plans to reduce its stake by up to 1.99% [19][20] Group 7 - Xingqi Eye Medicine completed the first subject enrollment for a Phase II clinical trial of its eye drop product [21] - Kute Intelligent's controlling shareholder plans to reduce its stake by up to 2% [22] - Dongcheng Pharmaceutical's subsidiary received approval for a new specification of a heparin sodium injection [23] Group 8 - Zhaoyi Innovation is in the process of issuing H-shares and has received regulatory approval [24] - Aokang International's shareholder plans to reduce its stake by up to 3% [25] - Jiamei Packaging's controlling shareholder is planning a change of control, leading to a temporary stock suspension [26] Group 9 - ST Kevin's stock will have its risk warning lifted and will resume trading [27] - Zaiseng Technology's controlling shareholder plans to transfer 6.04% of the company's shares [28] - Lide New Energy's shareholder plans to reduce its stake by up to 1% [29] Group 10 - Srypu terminated its plan to acquire shares and will resume trading [30] - Longjiang Transportation's subsidiary plans to invest 2.679 billion yuan in a graphite mining project [31] - Haowei Group's controlling shareholder has not reduced its stake and has terminated the reduction plan [32] Group 11 - Huilun Crystal received an administrative penalty notice for information disclosure violations [33] - Haiguang Information terminated a major asset restructuring plan [34] - Zhongke Shuguang announced a cash dividend plan [35] Group 12 - Fushuo Technology's share purchase plan was approved by the Shenzhen Stock Exchange [36] - Dongbai Group's shareholder reduced its stake by 25.95 million shares [38]
今日看点|2024-2025年度营响大会暨(第二十三届)杰出品牌营销年会将举行
Jing Ji Guan Cha Bao· 2025-12-10 01:04
Group 1 - The 2024-2025 Annual Marketing Conference and the 23rd Outstanding Brand Marketing Annual Meeting will be held in Beijing, focusing on the collision between brand economy and traffic economy, aiming to promote brand competition from "traffic competition" to "value cultivation" [1] - On December 10, a total of 1.41 million shares from 8 companies will be unlocked, with a total market value of 2.388 billion yuan, including significant unlocks from Nanshan Zhishang, Xingtong Co., and Yunding Technology [1] - The unlocked shares include over 10 million shares from three companies, with Nanshan Zhishang leading at 71.4286 million shares, followed by Xingtong Co. at 41.4916 million shares, and Yunding Technology at 10.0526 million shares [1] Group 2 - Nine companies disclosed stock repurchase progress on December 10, with five companies announcing new repurchase plans, one plan approved by shareholders, and three plans completed [2] - Among the new repurchase plans, four companies announced amounts exceeding 10 million yuan, with Huitai Medical, Songcheng Performance, and Jinggu Co. having the highest proposed repurchase amounts of 250 million yuan, 200 million yuan, and 60 million yuan respectively [2] - Huadong Medicine has the highest repurchase amount approved by shareholders, proposing to repurchase up to 6.494 million yuan [2]
每天三分钟公告很轻松 | 莱茵生物和嘉美包装控股股东筹划公司控制权变更 10日起停牌





Shang Hai Zheng Quan Bao· 2025-12-09 16:17
Group 1 - Rhein Biotech and Jia Mei Packaging's controlling shareholders are planning changes in company control, with trading suspension starting from December 10, 2025, for Rhein Biotech expected to last no more than 10 trading days and for Jia Mei Packaging no more than 2 trading days [1][2] - Rhein Biotech intends to acquire at least 80% of Beijing Jinkangpu Food Technology Co., Ltd. through a combination of issuing shares and cash payment, which will make Beijing Jinkangpu a subsidiary included in the consolidated financial statements [1] - Jia Mei Packaging's controlling shareholder is also in discussions regarding a potential change in control, with specific transaction details still under negotiation [2] Group 2 - Haiguang Information has terminated its plan to merge with Zhongke Shuguang through a share exchange, as approved in a board meeting on December 9, 2025 [3] - Huatai Medical plans to repurchase shares with a total amount not less than RMB 200 million and not exceeding RMB 250 million, with a repurchase price cap of RMB 315 per share [4] - Songcheng Performing Arts and Jingu Co., Ltd. also announced share repurchase plans, with Songcheng aiming for a total of RMB 100 million to RMB 200 million and Jingu targeting RMB 30 million to RMB 60 million [4] Group 3 - Xiamen Airport is planning to acquire 100% of the shares of Zhaoxiang Technology, a wholly-owned subsidiary of its controlling shareholder, Xiamen Xiangye Group [5] - Borui Communication intends to acquire 51% of Meijing Technology from related parties for a total price of RMB 66.49 million [6] - Gu Ao Technology's actual controller is planning a change in control, with trading suspension starting from December 8, 2025, and expected to last no more than 3 trading days [6] Group 4 - ST Kevin's application to revoke the risk warning on its stock has been approved, with trading suspension for one day on December 10, 2025, and resuming trading on December 11, 2025 [6] - Huailun Crystal's stock will be suspended for one day starting December 10, 2025, due to false disclosures in its annual reports for 2021 and 2022 [7] - The stock of Jia Ao Environmental Protection will also be suspended for one day on December 10, 2025, due to an administrative penalty notice received from the regulatory authority [12] Group 5 - The company Yongmota plans to invest approximately RMB 400 million in a new project for magnesium-aluminum alloy components for the automotive and robotics industries [20] - ST Ningke is executing a capital reserve transfer plan to increase its share capital, with a total share increase from 684.88 million to 1.62 billion shares [21] - Yingpais plans to increase its shareholding through a combination of bank loans and self-funding, with a total investment of no less than RMB 60 million and no more than RMB 120 million [22]
宋城演艺上市十五周年推出回购方案 回购规模1亿元至2亿元
Zheng Quan Ri Bao Wang· 2025-12-09 14:16
财务层面,宋城演艺具备实施本次回购的充分实力。截至2025年9月30日,公司合并报表总资产101.49 亿元、归属于上市公司股东的净资产83.71亿元,账面货币资金达30.96亿元。 一直以来,宋城演艺凭借独创的"主题公园+文化演艺"的经营模式,在全国运营着十多个景区、上百台 千古情及演艺秀,在剧院数、座位数、演出场次、观众人次、经营效益等方面处于领先地位。公司打造 的演艺综合体更能实现客群停留时长和边际收益的跃升,形成可复制、可迭代、可扩展的增长路径,已 依托杭州宋城、三亚千古情等品牌项目建立稳定现金流。 本报讯 (记者吴文婧)2025年12月9日,正是宋城演艺(300144)发展股份有限公司(以下简称"宋城 演艺",300144.SZ)登陆资本市场十五周年之际,当晚,宋城演艺发布股份回购方案,拟以自有资金1 亿元至2亿元通过集中竞价交易方式回购公司股份并全部注销。 根据公告,宋城演艺本次回购价格上限为12元/股;按上限测算,预计回购规模约833万股至1667万股, 占公司总股本的0.32%至0.63%。回购期限为股东大会审议通过之日起6个月内,资金全部来自公司自有 资金。 这一回购举措的推出是基于宋城演艺 ...
宋城演艺:关于回购公司股份方案的公告
Zheng Quan Ri Bao Zhi Sheng· 2025-12-09 14:16
(编辑 任世碧) 证券日报网讯 12月9日晚间,宋城演艺发布公告称,公司拟使用自有资金以集中竞价交易方式回购部分 公司股份,本次回购的公司股份将全部用于注销并减少注册资本。回购股份的资金总额:不低于人民币 1亿元(含本数)且不超过人民币2亿元(含本数);回购股份的价格:回购价格上限为12.00元/股;回 购股份的期限:自公司股东会审议通过本次回购方案之日起6个月内。 ...
宋城演艺:拟回购注销增强投资回报 彰显长期发展信心
Zheng Quan Shi Bao Wang· 2025-12-09 14:01
Group 1 - The core announcement from Songcheng Performance is the plan to repurchase shares using its own funds, with a total amount between 100 million and 200 million yuan, aimed at canceling the repurchased shares and reducing registered capital [1] - The maximum repurchase price is set at 12.00 yuan per share, which is 150% of the average trading price over the previous 30 trading days, estimating the repurchase quantity to be between 8.33 million and 16.67 million shares, representing 0.32% to 0.63% of the current total share capital [1] - The company emphasizes its recognition of intrinsic value and confidence in future development, highlighting stable operations and good financial health, with total assets of 10.149 billion yuan and net assets of 8.371 billion yuan as of September 30, 2025 [1] Group 2 - The repurchase initiative aligns with the regulatory call from the China Securities Regulatory Commission to enhance investor returns and promote share buybacks as a means of rewarding investors [2] - The company aims to convey a positive signal to the market through this share repurchase, which is expected to enhance earnings per share and shareholder returns, thereby boosting market confidence and laying a solid foundation for long-term high-quality development [2]